Beacon Equity Research Calls Zila, Inc. (ZILA) an “Absolute Bargain Right Now”
Zila, Inc. (ZILA) is dedicated to the prevention, detection and treatment of oral cancer and other periodontal diseases. The company’s flagship product, ViziLite Plus, is designed for the early detection of oral abnormalities that often lead to cancer. It is recognized as the first and only medical device that has been cleared by the FDA for use in a population at an increased risk for oral cancer. The company also designs, manufactures and markets an entire suite of proprietary products that are sold directly to dental professionals for periodontal disease. These products include the Rota-Dent powered toothbrush, the Pro-Select ultrasonic…